Favorable outcome of allogeneic hematopoietic stem cell transplantation followed by post-transplant treatment with imatinib in children with Philadelphia chromosome-positive acute lymphoblastic leukemia

BACKGROUND: Allogeneic hematopoietic stem cell transplantation (HSCT) is the preferred curative therapy for children with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL). We evaluated the treatment outcomes of children with Ph+ ALL who underwent allogeneic HSCT. METHODS: Fi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Res
Autors principals: Byun, Ye Jee, Suh, Jin Kyung, Lee, Seong Wook, Lee, Darae, Kim, Hyunjin, Choi, Eun Seok, Koh, Kyung-Nam, Im, Ho Joon, Seo, Jong Jin
Format: Artigo
Idioma:Inglês
Publicat: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4595580/
https://ncbi.nlm.nih.gov/pubmed/26457281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5045/br.2015.50.3.147
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars